The effects of arsenic exposure on blood pressure and early risk markers of cardiovascular disease: Evidence for population differences

Environmental Research

Volumn 140, Issue , 2015, Pages 32-36

  Ameer, Syeda Shegufta ^a   Engström, Karin ^a   Harari, Florencia ^b   Concha, Gabriela ^c   Vahter, Marie ^b   Broberg, Karin ^b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c National Food Agency   (Sweden)

Author keywords

ApoA; ApoB; Blood pressure; Hemoglobin; Interleukin

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; ARSENIC; HOMOCYSTEINE; TRIACYLGLYCEROL;

ARSENIC; CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); HEALTH IMPACT; HEALTH RISK; HYPERTENSION; METABOLITE; POLLUTION EXPOSURE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; PRIORITY JOURNAL; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; ADOLESCENT; CARDIOVASCULAR DISEASES; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; URINE; YOUNG ADULT;

ANDES; ARGENTINA;

ADOLESCENT; ADULT; AGED; ARSENIC; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84925452879     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.03.010     Document Type: Article

References (25)

1. Abhyankar L.N., Jones M.R., Gullar E., Navas-Acien A. Arsenic exposure and hypertension: a systemic review. Environ. Health Perspect. 2012, 120:494-500.
2. Balakumar P., Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc. Toxicol. 2009, 9(4):169-176.
3. Cho Y., Ahn K.H., Back M.J., Choi J.M., Ji J.E., Won J.H., et al. Age-related effects of sodium arsenite on splenocyte proliferation and TH1/TH2 cytokine production. Arch. Pharm. Res. 2012, 35:375-382.
4. Concha G., Nermell B., Vahter M. Spatial and temporal variations in arsenic exposure via drinking-water in northern Argentina. J. Health Popul. Nutr. 2006, 24:317-327.
5. Concha G., Broberg K., Grander M., Cardozo A., Palm B., Vahter M. High-level exposure to lithium, boron, cesium, and arsenic via drinking water in the andes of northern Argentina. Environ. Sci. Technol. 2010, 44:6875-6880.
6. Fangstrom B., Hamadani J., Nermell B., Grander M., Palm B., Vahter M. Impaired arsenic metabolism in children during weaning. Toxicol. Appl. Pharmacol. 2009, 239:208-214.
7. Findlay J.W., Dillard R.F. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007, 9:E260-E267.
8. Frisancho A.R. Developmental functional adaptation to high altitude: review. Am. J. Hum. Biol. 2013, 25:151-168.
9. Heck J.E., Chen Y., Grann V.R., Slavkovich V., Parvez F., Ahsan H. Arsenic exposure and anemia in Bangladesh: a population-based study. J. Occup. Environ. Med. 2008, 50:80-87.
10. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 1996, 104:620-628.
11. Hopenhayn C., Bush H.M., Bingcang A., Hertz-Picciotto I. Association between arsenic exposure from drinking water and anemia during pregnancy. J. Occup. Environ. Med. 2006, 48:635-643.
12. Hossain M.B., Vahter M., Concha G., Broberg K. Low-level environmental cadmium exposure is associated with DNA hypomethylation in Argentinean women. Environ. Health Perspect. 2012, 120:879-884.
13. Joseph J., Loscalzo J. Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology. Nutrients 2013, 5:3235-3256.
14. Karim M.R., Rahman M., Islam K., Mamun A.A., Hossain S., Hossain E., et al. Increases in oxidized low-density lipoproteins and other inflammatory and adhesion molecules with concomitant decrease in high-density lipoproteins in the individuals exposed to arsenic in Bangladesh. Toxicol. Sci. 2013, 135:17-25.
15. Moon K., Guallar E., Navas-Acien A. Arsenic exposure and cardiovascular disease: An updated systematic review. Curr. Atheroscler. Rep. 2012, 14:542-555.
16. Moon K., Guallar E., Umans J., Devereux R., et al. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. Ann. Intern. Med. 2013, 159:649-659.
17. Nassar A., Azab A.N. Effects of lithium on inflammation. ASC Chem. Neurosci. 2014, Epub ahead of print.
18. Nermell B., Lindberg A.L., Rahman M., Berglund M., Persson L.A., El Arifeen S., et al. Urinary arsenic concentration adjustment factors and malnutrition. Environ. Res. 2008, 106:212-218.
19. Pilsner J.R., Liu X., Ahsan H., Ilievski V., Slavkovich V., Levy D., Factor-Litvak P., Grazino J.H., Gamble M.V. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 2009, 117:254-260.
20. Shiue I., Hristova K. Higher urinary heavy metal, phthalate and arsenic concentrations accounted for 3-19% of the population attributable risk for high blood pressure: US NHANES 2009-2012. Hypertens. Res. 2014, 37:1075-1081. Epub ahead of print.
21. Soto-Pena G.A., Vega L. Arsenic interferes with the signaling transduction pathway of t cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol. Appl. Pharmacol. 2008, 230:216-226.
22. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107(2):312-323.
23. Tognon G., Berg C., Mehlig K., Thelle D., Strandhagen E., Gustavsson J., et al. Comparison of apolipoprotein (ApoB/ApoA-1) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus on obesity, diet and alcohol intake. PloS One 2012, 7:e40878.
24. Vahter M., Concha G., Nermell B., Nilsson R., Dulout F., Natarajan A.T. A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 1995, 293:455-462.
25. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.